Thursday, January 20, 2011
Judge Avern Cohn of the US District Court for the Eastern District of Michigan found claims of Novo Nordisk's US Patent No. 6,677,358, relating to Prandin (repaglinide ), invalid and unenforceable.
Intellectual property news affecting business and everyday life
0 Comments:
Post a Comment
<< Home